X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
adult (19) 19
female (19) 19
index medicus (19) 19
male (19) 19
middle aged (16) 16
drug therapy (14) 14
hiv infections - drug therapy (14) 14
human immunodeficiency virus--hiv (14) 14
hiv infection (13) 13
antiretroviral drugs (12) 12
hiv (12) 12
treatment outcome (12) 12
drug therapy, combination (10) 10
viral load (10) 10
infectious diseases (9) 9
tenofovir (9) 9
emtricitabine (8) 8
internal medicine (8) 8
safety (8) 8
abridged index medicus (7) 7
adults (7) 7
anti-hiv agents - adverse effects (7) 7
anti-hiv agents - therapeutic use (7) 7
antiretroviral therapy (7) 7
antiviral agents (7) 7
dosage and administration (7) 7
infections (7) 7
infectious disease (7) 7
medicine, general & internal (7) 7
ritonavir (7) 7
adenine - analogs & derivatives (6) 6
anti-hiv agents - administration & dosage (6) 6
clinical trials (6) 6
efavirenz (6) 6
hiv infections - virology (6) 6
hiv-1 (6) 6
immunology (6) 6
life sciences (6) 6
ritonavir - administration & dosage (6) 6
aged (5) 5
aids/hiv (5) 5
cd4 lymphocyte count (5) 5
darunavir (5) 5
deoxycytidine - analogs & derivatives (5) 5
drug resistance (5) 5
hepatitis (5) 5
mortality (5) 5
protease inhibitors (5) 5
ritonavir - therapeutic use (5) 5
rna, viral - blood (5) 5
viral load - drug effects (5) 5
adenine - therapeutic use (4) 4
adolescent (4) 4
cross infection (4) 4
double-blind method (4) 4
drug administration schedule (4) 4
efficacy (4) 4
health aspects (4) 4
hiv infections - complications (4) 4
hiv-1 - drug effects (4) 4
hiv-1 - isolation & purification (4) 4
mutation (4) 4
nosocomial infections (4) 4
organophosphonates - therapeutic use (4) 4
randomization (4) 4
ritonavir - adverse effects (4) 4
therapy (4) 4
adenine - administration & dosage (3) 3
adenine - adverse effects (3) 3
benzoxazines - therapeutic use (3) 3
care and treatment (3) 3
complications and side effects (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - adverse effects (3) 3
deoxycytidine - therapeutic use (3) 3
disease (3) 3
double-blind (3) 3
drug combinations (3) 3
emtricitabine - adverse effects (3) 3
france (3) 3
hiv patients (3) 3
hiv protease inhibitors - administration & dosage (3) 3
hiv protease inhibitors - adverse effects (3) 3
hiv-1-infected patients (3) 3
inhibitors (3) 3
lamivudine (3) 3
lamivudine - therapeutic use (3) 3
multidisciplinary sciences (3) 3
organophosphonates - administration & dosage (3) 3
organophosphonates - adverse effects (3) 3
patient outcomes (3) 3
patients (3) 3
research (3) 3
reverse transcriptase inhibitors - therapeutic use (3) 3
ribonucleic acid--rna (3) 3
rna-directed dna polymerase (3) 3
studies (3) 3
tenofovir - adverse effects (3) 3
young adult (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1098 - 1106
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9639, pp. 646 - 655
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 4, pp. 387 - 396
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 6, pp. 459 - 467
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 11, pp. 1283 - 1291
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV
Journal Article